Astellas Pharma US Inc. recalls Prograf (tacrolimus) capsules and 1 more
- Published
- 5 Feb 2025
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.
Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US Inc., Northbrook, IL 60062, NDC 0469-0647-73.
- Brand / company
- Astellas Pharma US Inc.
- Codes / lots
- Lot# 0E3353D, Exp 03/31/2026 | Lot# 0R3092A, EXP 03/31/2026
- Distribution
- Nationwide in the USA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 5 Feb 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.